Allergy To House Dust Mites clinical trials

Explore recruiting allergy to house dust mites clinical trials.

Recruiting allergy to house dust mites studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allergy To House Dust Mites trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Allergy To House Dust Mites trials by city

Allergy To House Dust Mites in Toronto Allergy To House Dust Mites in Vancouver Allergy To House Dust Mites in Montreal Allergy To House Dust Mites in Calgary Allergy To House Dust Mites in Edmonton Allergy To House Dust Mites in Ottawa Allergy To House Dust Mites in Winnipeg Allergy To House Dust Mites in Quebec City Allergy To House Dust Mites in Hamilton Allergy To House Dust Mites in Kitchener Allergy To House Dust Mites in London Allergy To House Dust Mites in Halifax Allergy To House Dust Mites in New York Allergy To House Dust Mites in Los Angeles Allergy To House Dust Mites in Chicago Allergy To House Dust Mites in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease